Literature DB >> 2791333

Hirschsprung's disease and Ondine's curse: further evidence for a distinct syndrome.

C Minutillo1, P J Pemberton, J Goldblatt.   

Abstract

Although Hirschsprung's disease is a relatively common congenital malformation, with an estimated incidence of about 1:5000, Primary Central Hypoventilation Syndrome (Ondine's curse) is exceedingly rare, with about 50 reported cases. We describe a patient with total colonic aganglionosis occurring together with failure of automatic control of respiration, specific facial dysmorphology and characteristic CT scan changes to substantiate further the syndromic nature of this association.

Entities:  

Mesh:

Year:  1989        PMID: 2791333     DOI: 10.1111/j.1399-0004.1989.tb03189.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  4 in total

Review 1.  Hirschsprung's disease as a neurochristopathy.

Authors:  G Martucciello
Journal:  Pediatr Surg Int       Date:  1997       Impact factor: 1.827

2.  A human yeast artificial chromosome containing the multiple endocrine neoplasia type 2B Ret mutation does not induce medullary thyroid carcinoma but does support the growth of kidneys and partially rescues enteric nervous system development in Ret-deficient mice.

Authors:  Michael A Skinner; Somasundaram Kalyanaraman; Shawn D Safford; Robert O Heuckeroth; Warren Tourtellotte; Dominique Goyeau; Paul Goodfellow; Jeffrey D Milbrandt; Alex Freemerman
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

Review 3.  Congenital central hypoventilation syndrome and Hirschsprung's disease.

Authors:  G D Croaker; E Shi; E Simpson; T Cartmill; D T Cass
Journal:  Arch Dis Child       Date:  1998-04       Impact factor: 3.791

Review 4.  Ondine-Hirschsprung syndrome (Haddad syndrome). Further delineation in two cases and review of the literature.

Authors:  A Verloes; C Elmer; D Lacombe; C Heinrichs; E Rebuffat; J L Demarquez; A Moncla; E Adam
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.